SecBot SecBot

Affordable Insulin Now Act of 2023

S. 954 Sen. Raphael Warnock (D-GA) In committee
Bill text PDF
  1. Introduced Mar 23
  2. Committee Mar 23
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Mar 23, 2023Next: Senate vote
1063d ago Nov 30, 2023: Committee on Banking, Housing, and Urban Affairs. Hearings held. Hearings printed: S.Hrg. 118-511.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 2 filings
Subscribe to see spend
Member trades
4trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 1Financials 1
Search all 2 companies, their asks and price moves Subscribe

Summary

Affordable Insulin Now Act of 2023

Full summary3 paragraphs

This bill limits cost-sharing for insulin under private health insurance and establishes a program to provide insulin to individuals without insurance.

Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.

Further, the Department of Health and Human Services (HHS) must enter into agreements with pharmacies or health care providers to provide insulin to individuals without insurance. HHS must pay such pharmacies or providers an amount equal to the difference between the out-of-pocket cost to the individual for a 30-day supply of such insulin products and $35.

Library of Congress summary, Mar 23, 2023

Summary versions
  • Introduced in SenateMar 23, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.